{"version":"1.0","provider_name":"Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare","provider_url":"https:\/\/ceptonstrategies.com\/en","author_name":"Marc-Olivier B\u00e9vierre","author_url":"https:\/\/ceptonstrategies.com\/en\/author\/marc-olivier\/","title":"How will Brexit affect the strategies of US biotechs? &#8211; Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"IN11q5bkDV\"><a href=\"https:\/\/ceptonstrategies.com\/en\/will-brexit-affect-strategies-us-biotechs\/\">How will Brexit affect the strategies of US biotechs?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/ceptonstrategies.com\/en\/will-brexit-affect-strategies-us-biotechs\/embed\/#?secret=IN11q5bkDV\" width=\"600\" height=\"338\" title=\"&#8220;How will Brexit affect the strategies of US biotechs?&#8221; &#8212; Consulting Firm in Pharmaceutical, MedTech &amp; Healthcare\" data-secret=\"IN11q5bkDV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script type=\"text\/javascript\">\n\/* <![CDATA[ *\/\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/* ]]> *\/\n<\/script>\n","thumbnail_url":"https:\/\/ceptonstrategies.com\/wp-content\/uploads\/2017\/12\/AAIAAQDGAAAAAQAAAAAAAA1FAAAAJDIyYmJmMTFhLTc0NzEtNDc1Ni1hMDBiLTJiMWZlYjdkN2EwNw.jpg","thumbnail_width":744,"thumbnail_height":400,"description":"How will Brexit affect the strategies of US biotechs already in the UK, in Europe, or about to cross the Atlantic? Dwight D. Eisenhower and Charles de Gaulle didn\u2019t necessarily see eye to eye on many things, but both understood the strategic advantage the UK could provide to the US to set foot in Europe. [&hellip;]"}